Nagpal Kamalpreet, Plantinga Theo S, Wong Joyce, Monks Brian G, Gay Nicholas J, Netea Mihai G, Fitzgerald Katherine A, Golenbock Douglas T
Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
J Biol Chem. 2009 Sep 18;284(38):25742-8. doi: 10.1074/jbc.M109.014886. Epub 2009 Jun 9.
The adapter protein MyD88 adapter-like (Mal), encoded by TIR-domain containing adapter protein (Tirap) (MIM 606252), is the most polymorphic of the five adapter proteins involved in Toll-like receptor signaling, harboring eight non-synonymous single nucleotide polymorphisms in its coding region. We screened reported mutations of Mal for activity in reporter assays to test the hypothesis that variants of Mal existed with altered signaling potential. A TIR domain variant, Mal D96N (rs8177400), was found to be inactive. In reconstituted cell lines, Mal D96N acted as a hypomorphic mutation, with impaired cytokine production and NF-kappaB activation upon lipopolysaccharide or PAM2CSK4 stimulation. Moreover, co-immunoprecipitation studies revealed that Mal D96N is unable to interact with MyD88, a prerequisite for downstream signaling to occur. Computer modeling data suggested that residue 96 resides in the MyD88 binding site, further supporting these findings. Genotyping of Mal D96N in three different cohorts suggested that it is a rare mutation. We, thus, describe a rare variant in Mal that exerts its effect via its inability to bind MyD88.
衔接蛋白髓样分化因子88衔接蛋白样分子(Mal)由含TIR结构域的衔接蛋白(Tirap)(MIM 606252)编码,是Toll样受体信号通路中涉及的五种衔接蛋白中多态性最高的,其编码区存在八个非同义单核苷酸多态性。我们在报告基因检测中筛选了已报道的Mal突变的活性,以检验存在具有改变的信号传导潜能的Mal变体这一假设。发现一种TIR结构域变体Mal D96N(rs8177400)无活性。在重组细胞系中,Mal D96N表现为一种亚效突变,在脂多糖或PAM2CSK4刺激下细胞因子产生和NF-κB激活受损。此外,免疫共沉淀研究表明,Mal D96N无法与MyD88相互作用,而这是下游信号传导发生的前提条件。计算机建模数据表明,96位残基位于MyD88结合位点,进一步支持了这些发现。在三个不同队列中对Mal D96N进行基因分型表明它是一种罕见突变。因此,我们描述了Mal中的一种罕见变体,它通过无法结合MyD88发挥作用。